What to do if Enterococcus faecalis (E. faecalis) colony-forming units (CFU) are greater than 100 three days after starting antibiotic treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Enterococcus faecalis with >100 CFU Three Days After Antibiotic Treatment

For persistent Enterococcus faecalis infection with colony counts >100 CFU after three days of antibiotic therapy, the most appropriate action is to reassess antibiotic selection and consider changing to ampicillin for ampicillin-susceptible strains or vancomycin for resistant strains, while removing any infected catheters if present. 1

Evaluation of Persistent Infection

When E. faecalis persists after initial antibiotic therapy, consider the following factors:

  1. Source of infection:

    • Determine if there is a catheter-related infection
    • Check for endocarditis, especially with persistent bacteremia
    • Evaluate for undrained abscesses or other foci of infection
  2. Current antibiotic regimen:

    • Verify appropriate antibiotic selection based on susceptibility
    • Assess dosing adequacy
    • Check for potential drug interactions reducing efficacy
  3. Antimicrobial susceptibility:

    • Review susceptibility testing results
    • Consider high-level aminoglycoside resistance (HLAR) if combination therapy was used

Treatment Recommendations

For Catheter-Related Infections:

  • Remove infected catheters if present, particularly with:

    • Insertion site/pocket infection
    • Suppurative thrombophlebitis
    • Persistent bacteremia
    • Sepsis or metastatic infection 1
  • Antibiotic selection:

    • Ampicillin is the drug of choice for ampicillin-susceptible enterococci
    • Vancomycin should be used if the pathogen is resistant to ampicillin 1
    • For ampicillin and vancomycin-resistant enterococci, consider linezolid or daptomycin based on susceptibility results 1, 2
  • Treatment duration:

    • 7-14 days for uncomplicated enterococcal infections where the catheter is removed 1
    • Longer duration (up to 4-6 weeks) for complicated infections like endocarditis 1

For Endocarditis Consideration:

  • Perform transesophageal echocardiography (TEE) if the patient has:

    • Signs/symptoms suggesting endocarditis (new murmur, embolic phenomena)
    • Prolonged bacteremia or fever (>72 hours after appropriate therapy)
    • Radiographic evidence of septic pulmonary emboli
    • Prosthetic valve or other endovascular foreign bodies 1
  • Antibiotic regimens for endocarditis:

    • Ampicillin plus ceftriaxone is recommended for E. faecalis endocarditis 1
    • For aminoglycoside-resistant strains, double β-lactam therapy is reasonable 1

Follow-up Recommendations

  • Repeat blood cultures to document clearance of bacteremia
  • Remove catheter if persistent bacteremia (>72 hours after appropriate therapy) is detected 1
  • Consider antibiotic lock therapy in addition to systemic therapy if long-term catheter must be retained 1

Common Pitfalls to Avoid

  1. Using ineffective antibiotics:

    • Avoid cephalosporin monotherapy, as E. faecalis is intrinsically resistant 3
    • Don't use clindamycin or trimethoprim-sulfamethoxazole as monotherapy 3
  2. Inadequate source control:

    • Failure to remove infected catheters or drain abscesses
    • Overlooking potential endocarditis
  3. Insufficient treatment duration:

    • While 7 days may be sufficient for uncomplicated catheter-related infections 4, more complex infections require longer treatment
  4. Missing synergistic resistance:

    • Failing to identify high-level aminoglycoside resistance when using combination therapy

Special Considerations

  • For patients requiring outpatient parenteral antimicrobial therapy for E. faecalis endocarditis, combination regimens of ampicillin plus ceftriaxone have been successfully used 5, 6
  • In pediatric patients with recurrent urinary tract infections, E. faecalis may persist despite prophylaxis, and alternative approaches may be needed 7

By following these guidelines and addressing the specific factors contributing to persistent E. faecalis infection, you can optimize treatment outcomes and reduce the risk of complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment duration for central line-associated infection caused by Enterococcus spp.: a retrospective evaluation of a multicenter cohort.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.